ketoconazole has been researched along with Candidiasis, Chronic Mucocutaneous in 60 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Candidiasis, Chronic Mucocutaneous: A clinical syndrome characterized by development, usually in infancy or childhood, of a chronic, often widespread candidiasis of skin, nails, and mucous membranes. It may be secondary to one of the immunodeficiency syndromes, inherited as an autosomal recessive trait, or associated with defects in cell-mediated immunity, endocrine disorders, dental stomatitis, or malignancy.
Excerpt | Relevance | Reference |
---|---|---|
"Long-term results of initial ketoconazole treatment were evaluated in 13 patients with chronic mucocutaneous candidiasis followed up for 3 years." | 9.06 | Ketoconazole treatment of 13 patients with chronic mucocutaneous candidiasis. A prospective 3-year trial. ( Mobacken, H; Moberg, S, 1986) |
"Ketoconazole, a new oral antifungal agent, was evaluated in the treatment of four patients with severe chronic mucocutaneous candidiasis refractory to standard antifungal therapy." | 9.05 | Successful treatment of chronic mucocutaneous candidiasis with ketoconazole. ( Ament, ME; Byrne, W; Graybill, J; Rosenblatt, HM; Stiehm, ER, 1980) |
"Twelve patients with chronic mucocutaneous candidiasis were assigned by random allocation to a 6-month course of treatment with ketoconazole or placebo in a double-blind trial." | 9.05 | Treatment of chronic mucocutaneous candidiasis with ketoconazole: a controlled clinical trial. ( Alling, DW; Kirkpatrick, CH; Petersen, EA, 1980) |
"A case of monilial granuloma of 12 years duration is being successfully treated with ketoconazole administered orally in doses of 200 mg per day." | 7.67 | [Monilial granuloma treated successfully with ketoconazole over a period of 30 months]. ( Deschamps, P; Leroy, D; Mahoudeau, J; Michel, M; Vion, M, 1984) |
"The authors report the results of treatment with ketoconazole in 8 patients with chronic mucocutaneous candidiasis (CMC)." | 7.67 | Ketoconazole treatment of chronic mucocutaneous candidiasis. ( Montagnani, A; Negosanti, M; Patrizi, A, 1986) |
"Thirty-two diabetic patients with vaginal candidiasis were treated orally with 400 mg ketoconazole once daily for five days." | 7.67 | Treatment with ketoconazole in diabetic patients with vaginal candidiasis. ( Balbi, C; Balbi, GC; D'Ajello, M, 1986) |
"We report the clinical and laboratory findings in two children with chronic mucocutaneous candidiasis (CMC) treated successfully with intermittent long-term ketoconazole therapy." | 7.66 | Intermittent ketoconazole therapy of chronic mucocutaneous candidiasis in childhood. ( Fanconi, S; Issler, C; Joller, P; Schär, G; Seger, R, 1982) |
"An 8-year-old girl with chronic mucocutaneous candidiasis was treated with Ketoconazole 100 mg daily for 6 weeks." | 7.66 | Ketoconazole in a case of chronic mucocutaneous candidiasis. ( Laurberg, G; Thestrup-Pedersen, K; Zachariae, H, 1982) |
"Five patients received ketoconazole treatment of chronic mucocutaneous candidiasis." | 7.66 | Ketoconazole treatment of chronic mucocutaneous candidiasis. ( Graybill, JR; Herndon, JH; Kniker, WT; Levine, HB, 1980) |
"A father and son, both suffering from chronic mucocutaneous candidiasis, were successfully treated with oral ketoconazole, a water-soluble imidazole compound." | 7.66 | Familial chronic mucocutaneous candidiasis successfully treated with oral ketoconazole. ( Anderson, R; Morrison, JG, 1981) |
"Our experience in the treatment of chronic mucocutaneous candidiasis with ketoconazole is reviewed." | 7.66 | Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole: experience with twenty-one patients. ( Horsburgh, CR; Kirkpatrick, CH, 1983) |
"Forty-eight cases of deep mycoses were studied and treated with ketoconazole, each with in vitro evaluation of the minimum inhibitory concentrations (MIC) of the causative fungi, in vivo pharmacokinetic, clinical, and mycologic evaluations, several months to two years after the treatment was stopped." | 7.66 | Laboratory and clinical assessment of ketoconazole in deep-seated mycoses. ( Drouhet, E; Dupont, B, 1983) |
" She was treated continuously for 6 years with ketoconazole at the same dosage of 200 mg/day." | 5.28 | Aneurysm associated with chronic mucocutaneous candidiasis during long-term therapy with ketoconazole. ( Dompmartin, A; Houtteville, JP; Leroy, D; Theron, J, 1989) |
"Chronic mucocutaneous candidiasis is an immunodeficiency disorder which has significant morbidity due to mucous membrane, skin and nail infection." | 5.27 | Ketoconazole treatment of nail infection in chronic mucocutaneous candidiasis. ( Hosking, CS; Roberton, DM, 1983) |
"Long-term results of initial ketoconazole treatment were evaluated in 13 patients with chronic mucocutaneous candidiasis followed up for 3 years." | 5.06 | Ketoconazole treatment of 13 patients with chronic mucocutaneous candidiasis. A prospective 3-year trial. ( Mobacken, H; Moberg, S, 1986) |
"Ketoconazole, a new oral antifungal agent, was evaluated in the treatment of four patients with severe chronic mucocutaneous candidiasis refractory to standard antifungal therapy." | 5.05 | Successful treatment of chronic mucocutaneous candidiasis with ketoconazole. ( Ament, ME; Byrne, W; Graybill, J; Rosenblatt, HM; Stiehm, ER, 1980) |
"Twelve patients with chronic mucocutaneous candidiasis were assigned by random allocation to a 6-month course of treatment with ketoconazole or placebo in a double-blind trial." | 5.05 | Treatment of chronic mucocutaneous candidiasis with ketoconazole: a controlled clinical trial. ( Alling, DW; Kirkpatrick, CH; Petersen, EA, 1980) |
"A case of monilial granuloma of 12 years duration is being successfully treated with ketoconazole administered orally in doses of 200 mg per day." | 3.67 | [Monilial granuloma treated successfully with ketoconazole over a period of 30 months]. ( Deschamps, P; Leroy, D; Mahoudeau, J; Michel, M; Vion, M, 1984) |
"The authors report the results of treatment with ketoconazole in 8 patients with chronic mucocutaneous candidiasis (CMC)." | 3.67 | Ketoconazole treatment of chronic mucocutaneous candidiasis. ( Montagnani, A; Negosanti, M; Patrizi, A, 1986) |
"Thirty-two diabetic patients with vaginal candidiasis were treated orally with 400 mg ketoconazole once daily for five days." | 3.67 | Treatment with ketoconazole in diabetic patients with vaginal candidiasis. ( Balbi, C; Balbi, GC; D'Ajello, M, 1986) |
"An 8-year-old girl with chronic mucocutaneous candidiasis was treated with Ketoconazole 100 mg daily for 6 weeks." | 3.66 | Ketoconazole in a case of chronic mucocutaneous candidiasis. ( Laurberg, G; Thestrup-Pedersen, K; Zachariae, H, 1982) |
"Five patients received ketoconazole treatment of chronic mucocutaneous candidiasis." | 3.66 | Ketoconazole treatment of chronic mucocutaneous candidiasis. ( Graybill, JR; Herndon, JH; Kniker, WT; Levine, HB, 1980) |
"A father and son, both suffering from chronic mucocutaneous candidiasis, were successfully treated with oral ketoconazole, a water-soluble imidazole compound." | 3.66 | Familial chronic mucocutaneous candidiasis successfully treated with oral ketoconazole. ( Anderson, R; Morrison, JG, 1981) |
"Ketoconazole is an effective treatment for chronic superficial candidiasis as well as chronic dermatophytosis." | 3.66 | Ketoconazole in the treatment of fungal infection. Clinical and laboratory studies. ( Hay, RJ, 1983) |
"Clinical observations made on a group of six children and three adults indicate that ketoconazole is a safe and effective fungistatic agent that is useful for both initial and long-term maintenance therapy of mucocutaneous lesions due to infection by sensitive strains of Candida in patients with chronic mucocutaneous candidiasis." | 3.66 | Therapy of chronic mucocutaneous candidiasis. ( Rosenblatt, HM; Stiehm, ER, 1983) |
"Our experience in the treatment of chronic mucocutaneous candidiasis with ketoconazole is reviewed." | 3.66 | Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole: experience with twenty-one patients. ( Horsburgh, CR; Kirkpatrick, CH, 1983) |
"Forty-eight cases of deep mycoses were studied and treated with ketoconazole, each with in vitro evaluation of the minimum inhibitory concentrations (MIC) of the causative fungi, in vivo pharmacokinetic, clinical, and mycologic evaluations, several months to two years after the treatment was stopped." | 3.66 | Laboratory and clinical assessment of ketoconazole in deep-seated mycoses. ( Drouhet, E; Dupont, B, 1983) |
"We report the clinical and laboratory findings in two children with chronic mucocutaneous candidiasis (CMC) treated successfully with intermittent long-term ketoconazole therapy." | 3.66 | Intermittent ketoconazole therapy of chronic mucocutaneous candidiasis in childhood. ( Fanconi, S; Issler, C; Joller, P; Schär, G; Seger, R, 1982) |
"Ketoconazole was administered as a single daily oral dose of 200 mg to 12 patients with chronic mucocutaneous candidosis (CMC) of autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy (APECED)." | 2.66 | Ketoconazole is effective against the chronic mucocutaneous candidosis of autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy (APECED). ( Ahonen, P; Kahanpää, A; Myllärniemi, S; Perheentupa, J, 1986) |
"Chronic mucocutaneous candidiasis is a immuno deficiency disorder primarily due to T cell dysfunction characterized by persistent candidal infection of mucous membrane, skin, scalp and nails." | 1.32 | Chronic mucocutaneous candidiasis: a case report. ( Bhowate, R; Dubey, A, 2004) |
"Ketoconazole was effective in controlling symptoms of candidiasis in most patients." | 1.28 | Chronic mucocutaneous candidiasis in childhood and complications of non-Candida infection: a report of the Pediatric Immunodeficiency Collaborative Study Group. ( Herrod, HG, 1990) |
" She was treated continuously for 6 years with ketoconazole at the same dosage of 200 mg/day." | 1.28 | Aneurysm associated with chronic mucocutaneous candidiasis during long-term therapy with ketoconazole. ( Dompmartin, A; Houtteville, JP; Leroy, D; Theron, J, 1989) |
"Chronic mucocutaneous candidiasis is an immunodeficiency disorder which has significant morbidity due to mucous membrane, skin and nail infection." | 1.27 | Ketoconazole treatment of nail infection in chronic mucocutaneous candidiasis. ( Hosking, CS; Roberton, DM, 1983) |
"Chronic mucocutaneous candidiasis is a chronic infection of mucoses, nails and skin due to Candida sp." | 1.27 | [Chronic mucocutaneous candidiasis]. ( de Moragas, JM; García, MP; Pérez, M; Puig, L, 1988) |
"Candidiasis was characterized by purulent nasal discharge, inflammation of the lips at the mucocutaneous junction, periocular alopecia, vaginitis, and dermatitis." | 1.27 | Candidiasis in captive pinnipeds. ( Buck, JD; Dunn, JL; Spotte, S, 1984) |
"Ketoconazole has been shown to be effective in the treatment of mucocutaneous candidiasis with a reported 97% positive response rate." | 1.27 | Ketoconazole and the antifungals. ( Parkin, JL, 1985) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 50 (83.33) | 18.7374 |
1990's | 4 (6.67) | 18.2507 |
2000's | 6 (10.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Katoh, T | 1 |
Hassan, G | 1 |
Bhowate, R | 1 |
Dubey, A | 1 |
San Filippo, J | 1 |
Corbeel, L | 1 |
Ceuppens, JL | 1 |
Van den Berghe, G | 1 |
Claeys, H | 1 |
Casteels-Van Daele, M | 1 |
Dunn, JL | 1 |
Buck, JD | 1 |
Spotte, S | 1 |
Warnock, DW | 2 |
Johnson, EM | 2 |
Richardson, MD | 1 |
Vickers, CF | 1 |
Zachariae, H | 1 |
Laurberg, G | 1 |
Thestrup-Pedersen, K | 1 |
Coovadia, HM | 1 |
Hamed, Z | 1 |
Bayles, MA | 1 |
Kiepiela, P | 1 |
Rosenblatt, HM | 2 |
Byrne, W | 1 |
Ament, ME | 1 |
Graybill, J | 1 |
Stiehm, ER | 3 |
Graybill, JR | 2 |
Herndon, JH | 1 |
Kniker, WT | 1 |
Levine, HB | 1 |
Check, WA | 1 |
Petersen, EA | 1 |
Alling, DW | 1 |
Kirkpatrick, CH | 2 |
Drutz, DJ | 1 |
Murphy, AL | 1 |
Morrison, JG | 1 |
Anderson, R | 1 |
Kennedy, CT | 2 |
Valdimarsson, H | 1 |
Hay, RJ | 3 |
Clayton, YM | 1 |
Tkach, JR | 1 |
Rinaldi, MG | 1 |
Appleboom, TM | 1 |
Flowers, FP | 1 |
Egere, JU | 1 |
Gugnani, HC | 1 |
Nzelibe, FK | 1 |
Horsburgh, CR | 1 |
Drouhet, E | 2 |
Dupont, B | 1 |
Fanconi, S | 1 |
Seger, R | 1 |
Joller, P | 1 |
Issler, C | 1 |
Schär, G | 1 |
Williamson, MM | 1 |
Gordon, RD | 1 |
Palestine, RF | 1 |
Su, WP | 1 |
Liesegang, TJ | 1 |
Roberton, DM | 1 |
Hosking, CS | 1 |
Collins, JR | 1 |
Van Sickels, JE | 1 |
Ryley, JF | 1 |
Wilson, RG | 1 |
Barrett-Bee, KJ | 1 |
Deutsch, PH | 1 |
Quintiliani, R | 1 |
Zouali, M | 1 |
Eyquem, A | 1 |
García-Pérez, A | 1 |
Gómez de la Concha, E | 1 |
Guerra Rodríguez, P | 1 |
Leroy, D | 2 |
Michel, M | 1 |
Vion, M | 1 |
Mahoudeau, J | 1 |
Deschamps, P | 1 |
Zeldis, JB | 1 |
Lamb, DC | 1 |
Kelly, DE | 1 |
Manning, NJ | 1 |
Kelly, SL | 1 |
Burgaleta, C | 1 |
Ree, T | 1 |
Jennings, PR | 1 |
Ofotokun, I | 1 |
Herrod, HG | 2 |
Mobacken, H | 2 |
Lindholm, L | 1 |
Moberg, S | 2 |
Dompmartin, A | 1 |
Houtteville, JP | 1 |
Theron, J | 1 |
Burke, WA | 1 |
Drew, RH | 1 |
Perfect, JR | 1 |
Gallis, HA | 1 |
Zaias, N | 1 |
Smith, KJ | 1 |
Hopwood, V | 1 |
Van Cutsem, J | 1 |
Vanden Bossche, H | 1 |
García, MP | 1 |
Puig, L | 1 |
Pérez, M | 1 |
de Moragas, JM | 1 |
Kitching, NH | 1 |
Tanner, AR | 1 |
Montagnani, A | 1 |
Negosanti, M | 1 |
Patrizi, A | 1 |
Ahonen, P | 1 |
Myllärniemi, S | 1 |
Kahanpää, A | 1 |
Perheentupa, J | 1 |
Pérez Suárez de Durandeau, L | 1 |
Salinas Carmona, MC | 1 |
Silva Siwady, JG | 1 |
Hinojosa Ayala, JR | 1 |
Flynn, PM | 1 |
Barrett, FF | 1 |
Balbi, C | 1 |
D'Ajello, M | 1 |
Balbi, GC | 1 |
Wengrower, D | 1 |
Rave, D | 1 |
Kleinman, Y | 1 |
Daugaard, K | 1 |
Nielsen, H | 1 |
Schiodt, M | 1 |
Parkin, JL | 1 |
Selkin, SG | 1 |
Haas, A | 1 |
4 reviews available for ketoconazole and Candidiasis, Chronic Mucocutaneous
Article | Year |
---|---|
[Guidelines for diagnosis and treatment of mucocutaneous candidiasis].
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Candida albicans; Candidiasis, Chr | 2009 |
Chronic mucocutaneous candidiasis associated with malignant thymoma and systemic lupus erythematosus with hypergammaglobulinemia: a case report and literature review.
Topics: Adult; Antifungal Agents; Candidiasis, Chronic Mucocutaneous; Humans; Hypergammaglobulinemia; Itraco | 2006 |
Ketoconazole.
Topics: Candidiasis; Candidiasis, Chronic Mucocutaneous; Candidiasis, Oral; Chemical Phenomena; Chemistry; C | 1984 |
[Prevention and treatment of invasive mycoses in patients with neutropenia and bone marrow transplantation].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Candidia | 1995 |
6 trials available for ketoconazole and Candidiasis, Chronic Mucocutaneous
Article | Year |
---|---|
Successful treatment of chronic mucocutaneous candidiasis with ketoconazole.
Topics: Adult; Antifungal Agents; Candida; Candidiasis; Candidiasis, Chronic Mucocutaneous; Child; Clinical | 1980 |
Oral antifungal agent effective even for widespread infections.
Topics: Administration, Oral; Antifungal Agents; Candidiasis, Chronic Mucocutaneous; Clinical Trials as Topi | 1980 |
Treatment of chronic mucocutaneous candidiasis with ketoconazole: a controlled clinical trial.
Topics: Adolescent; Adult; Candidiasis; Candidiasis, Chronic Mucocutaneous; Child; Clinical Trials as Topic; | 1980 |
Ketoconazole: a major innovation for treatment of fungal disease.
Topics: Animals; Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Clinical Trials as Topi | 1980 |
Ketoconazole treatment of 13 patients with chronic mucocutaneous candidiasis. A prospective 3-year trial.
Topics: Administration, Oral; Adolescent; Adult; Candidiasis; Candidiasis, Chronic Mucocutaneous; Child; Chi | 1986 |
Ketoconazole is effective against the chronic mucocutaneous candidosis of autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy (APECED).
Topics: Adolescent; Adrenal Insufficiency; Adult; Autoimmune Diseases; Candidiasis; Candidiasis, Chronic Muc | 1986 |
50 other studies available for ketoconazole and Candidiasis, Chronic Mucocutaneous
Article | Year |
---|---|
Terbinafine effectiveness in ketoconazole-resistant mucocutaneous candidasis in polyglandular autoimmune syndrome type 1.
Topics: Antifungal Agents; Candidiasis, Chronic Mucocutaneous; Drug Resistance, Fungal; Humans; Ketoconazole | 2003 |
Chronic mucocutaneous candidiasis: a case report.
Topics: Antifungal Agents; Autoimmunity; Candidiasis, Chronic Mucocutaneous; Candidiasis, Oral; Child; Femal | 2004 |
Immunological observations before and after successful treatment of chronic mucocutaneous candidiasis with ketoconazole and transfer factor.
Topics: Antibody Formation; Candida albicans; Candidiasis; Candidiasis, Chronic Mucocutaneous; Chemotaxis, L | 1984 |
Candidiasis in captive pinnipeds.
Topics: Animals; Animals, Wild; Birds; Candida albicans; Candidiasis; Candidiasis, Chronic Mucocutaneous; Ca | 1984 |
Modified response to ketoconazole of Candida albicans from a treatment failure.
Topics: Antifungal Agents; Candida albicans; Candidiasis, Chronic Mucocutaneous; Child; Drug Resistance, Mic | 1983 |
Ketoconazole in a case of chronic mucocutaneous candidiasis.
Topics: Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Child; Child, Preschool; Female; | 1982 |
Chronic mucocutaneous candidiasis with IgA deficiency in a two-year-old African girl who responded well to ketoconazole.
Topics: Candidiasis; Candidiasis, Chronic Mucocutaneous; Child, Preschool; Dysgammaglobulinemia; Facial Derm | 1983 |
Ketoconazole treatment of chronic mucocutaneous candidiasis.
Topics: Adolescent; Adult; Candidiasis; Candidiasis, Chronic Mucocutaneous; Candidiasis, Oral; Cryptococcosi | 1980 |
Familial chronic mucocutaneous candidiasis successfully treated with oral ketoconazole.
Topics: Administration, Oral; Adult; Candidiasis; Candidiasis, Chronic Mucocutaneous; Candidiasis, Oral; Hum | 1981 |
Chronic mucocutaneous candidiasis with a serum-dependent neutrophil defect: response to ketoconazole.
Topics: Adult; Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Female; Humans; Imidazole | 1981 |
The treatment of patients with chronic mucocutaneous candidosis and candida onychomycosis with ketoconazole.
Topics: Candidiasis; Candidiasis, Chronic Mucocutaneous; Humans; Imidazoles; Ketoconazole; Piperazines | 1982 |
Severe hepatitis associated with ketoconazole therapy for chronic mucocutaneous candidiasis.
Topics: Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Chemical and Drug Induced Liver | 1982 |
Ketoconazole in the treatment of chronic mucocutaneous candidiasis secondary to autoimmune polyendocrinopathy-candidiasis syndrome.
Topics: Adolescent; Antifungal Agents; Autoimmune Diseases; Candidiasis; Candidiasis, Chronic Mucocutaneous; | 1982 |
Chronic mucocutaneous candidiasis treated with ketoconazole.
Topics: Candidiasis; Candidiasis, Chronic Mucocutaneous; Child; Humans; Imidazoles; Infant; Ketoconazole; Ma | 1982 |
Ketoconazole in the treatment of fungal infection. Clinical and laboratory studies.
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Dermatomycose | 1983 |
Therapy of chronic mucocutaneous candidiasis.
Topics: Adult; Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Child; Drug Administratio | 1983 |
Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole: experience with twenty-one patients.
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Chemical and | 1983 |
Laboratory and clinical assessment of ketoconazole in deep-seated mycoses.
Topics: Adolescent; Adult; Antifungal Agents; Arthritis, Infectious; Blastomycosis; Candidiasis; Candidiasis | 1983 |
Intermittent ketoconazole therapy of chronic mucocutaneous candidiasis in childhood.
Topics: Administration, Oral; Adolescent; Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous | 1982 |
Severe chronic mucocutaneous candidiasis. Favourable response to oral therapy with ketoconazole.
Topics: Adolescent; Body Height; Candidiasis; Candidiasis, Chronic Mucocutaneous; Esophageal Stenosis; Human | 1983 |
Late-onset chronic mucocutaneous and ocular candidiasis and malignant thymoma.
Topics: Candidiasis; Candidiasis, Chronic Mucocutaneous; Conjunctival Diseases; Humans; Imidazoles; Ketocona | 1983 |
Ketoconazole treatment of nail infection in chronic mucocutaneous candidiasis.
Topics: Adolescent; Candidiasis; Candidiasis, Chronic Mucocutaneous; Child; Child, Preschool; Female; Humans | 1983 |
Chronic mucocutaneous candidiasis.
Topics: Candidiasis; Candidiasis, Chronic Mucocutaneous; Candidiasis, Oral; Clotrimazole; Humans; Infant; Ke | 1983 |
Azole resistance in Candida albicans.
Topics: Amino Acids; Animals; Antifungal Agents; Candida albicans; Candidiasis, Chronic Mucocutaneous; Candi | 1984 |
Evaluation of auto-antibodies in chronic mucocutaneous candidiasis without endocrinopathy.
Topics: Adolescent; Adult; Antibodies, Antinuclear; Antibodies, Fungal; Antibody Formation; Autoantibodies; | 1984 |
[Familial chronic mucocutaneous candidiasis. Study of 2 families].
Topics: Adolescent; Adult; Amphotericin B; Candidiasis; Candidiasis, Chronic Mucocutaneous; Consanguinity; F | 1984 |
[Monilial granuloma treated successfully with ketoconazole over a period of 30 months].
Topics: Adolescent; Candidiasis; Candidiasis, Chronic Mucocutaneous; Facial Dermatoses; Granuloma; Hand Derm | 1984 |
HIV-related skin diseases.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Chronic Mucocutaneous; Humans | 1996 |
Reduced intracellular accumulation of azole antifungal results in resistance in Candida albicans isolate NCPF 3363.
Topics: Antifungal Agents; Candida albicans; Candidiasis, Chronic Mucocutaneous; Drug Resistance, Microbial; | 1997 |
Chronic mucocutaneous candidiasis.
Topics: Adult; Antifungal Agents; Candidiasis, Chronic Mucocutaneous; Diagnosis, Differential; Female; Human | 2002 |
[Candida infection of the skin and mucous membranes still a topic. Administering azoles with clinical understanding].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Antiretroviral Therapy, Highly Active; Can | 2002 |
Chronic mucocutaneous candidiasis in childhood and complications of non-Candida infection: a report of the Pediatric Immunodeficiency Collaborative Study Group.
Topics: Adolescent; Amphotericin B; Autoimmune Diseases; Candidiasis; Candidiasis, Chronic Mucocutaneous; Ch | 1990 |
Immunological studies in chronic mucocutaneous candidiasis before and after ketoconazole treatment.
Topics: Adolescent; Adult; Antigen-Antibody Complex; Candidiasis; Candidiasis, Chronic Mucocutaneous; Child; | 1987 |
Aneurysm associated with chronic mucocutaneous candidiasis during long-term therapy with ketoconazole.
Topics: Adult; Aneurysm, Infected; Candidiasis; Candidiasis, Chronic Mucocutaneous; Dose-Response Relationsh | 1989 |
Use of itraconazole in a patient with chronic mucocutaneous candidiasis.
Topics: Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Child; Humans; Itraconazole; Ket | 1989 |
Use of fluconazole in a patient with documented malabsorption of ketoconazole.
Topics: Administration, Oral; Adult; Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Fem | 1988 |
Onychomycosis.
Topics: Adult; Candida albicans; Candidiasis, Chronic Mucocutaneous; Foot Dermatoses; Glutaral; Griseofulvin | 1985 |
Azole resistance in Candida albicans.
Topics: Adult; Animals; Antifungal Agents; Candida albicans; Candidiasis; Candidiasis, Chronic Mucocutaneous | 1986 |
[Chronic mucocutaneous candidiasis].
Topics: Adult; Candidiasis; Candidiasis, Chronic Mucocutaneous; Child; Cimetidine; Drug Therapy, Combination | 1988 |
Hypothyroidism after treatment with ketoconazole.
Topics: Adult; Candidiasis, Chronic Mucocutaneous; Candidiasis, Oral; Child; Humans; Hypothyroidism; Ketocon | 1986 |
Hypothyroidism after treatment with ketoconazole.
Topics: Candidiasis; Candidiasis, Chronic Mucocutaneous; Humans; Hypothyroidism; Ketoconazole; Male | 1987 |
Ketoconazole treatment of chronic mucocutaneous candidiasis.
Topics: Adolescent; Adult; Aged; Candidiasis; Candidiasis, Chronic Mucocutaneous; Child; Drug Administration | 1986 |
[Chronic mucocutaneous candidiasis. Cutaneous expression of immunologic anomalies. Report of a case].
Topics: Candidiasis; Candidiasis, Chronic Mucocutaneous; Child; Female; Humans; Immunity, Cellular; Ketocona | 1986 |
Disseminated histoplasmosis in two patients with chronic mucocutaneous candidiasis.
Topics: Adult; Amphotericin B; Candidiasis; Candidiasis, Chronic Mucocutaneous; Child; Female; Histoplasmosi | 1987 |
Treatment with ketoconazole in diabetic patients with vaginal candidiasis.
Topics: Administration, Oral; Adult; Candidiasis; Candidiasis, Chronic Mucocutaneous; Diabetes Complications | 1986 |
[Chronic mucocutaneous candidiasis].
Topics: Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Female; Humans; Ketoconazole; Mi | 1986 |
Chronic mucocutaneous candidiasis treated with ketoconazole (Nizoral).
Topics: Candidiasis; Candidiasis, Chronic Mucocutaneous; Candidiasis, Oral; Child; Facial Dermatoses; Humans | 1985 |
Ketoconazole and the antifungals.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Humans; Ketocona | 1985 |
Laryngeal candidiasis and ketoconazole.
Topics: Candidiasis; Candidiasis, Chronic Mucocutaneous; Female; Humans; Ketoconazole; Laryngeal Diseases; M | 1985 |
The "yeast connection" meets chronic mucocutaneous candidiasis.
Topics: Candidiasis; Candidiasis, Chronic Mucocutaneous; Child, Preschool; Humans; Ketoconazole; Male; Nysta | 1986 |